期刊文献+

GHRPs对CHF大鼠存活时间影响及心脏活性研究 被引量:1

Study on the Effect of GHRPs on Survival Time and Cardioprotective Function in Rats with CHF
下载PDF
导出
摘要 目的研究GHRPs对ADR诱导的CHF大鼠存活时间影响,探索CHRPs的CHF直接治疗作用及其心脏保护性作用机制,为CHF生物学治疗提供新方法、新途径。方法采用ADR经ip制作CHF大鼠模型,尾静脉注射法分别给GHRPs和复方丹参和生理盐水,观察4组CHF大鼠存活时间。结果ADR大鼠CHF模型基本符合临床心肌病性CHF的病理生理过程;GH—RPs和复方丹参都能延长CHF大鼠存活时间,总计GHRPs比复方丹参组多存活15~17天。结论复方丹参和GHRPs均能改善重症CHF大鼠恶液质状态,延长其存活时间,GHRPs的心脏保护作用比复方丹参更强。 Objective To observe the effect of GHRPs on the survival time in CHF model of rats in a purpose to explore the cardioprotective effect mechanisms of GHRPs on heart,so as to provide new method,new pathway for CHF biological therapy. Methods The establishment of rat CHF model was caused by ADR and the survival time in the four group rats with serious CHF after the different therapy through injection of GHRP- 2, GHRP -6, eoumpound recipe Danshen or NaCl into tail vein was observed. Results The rat model of ADR - induced CHF basically hit the target of Bishop indexes of CHF which suggested that the CHF model of rats reduced by ADR was successfully similar with the pathological processes of cardiomyopathy style CHF. Both GHRPs and the coumpound recipe Danshen could prolong the survival time in rats with serious CHF reduced by ADR and the GHRPs groups were 15 to 17 days longer than the lateral one. Conclusion Both GHRPs and the coumpound recipe Danshen could ameliorate the dyscrasia condition and prolong the survival time in rats with serious CHF,and the cardiaoprotective activity of GHRPs was much stronger compared with the coumpound recipe Danshen.
出处 《医学研究杂志》 2011年第8期82-84,共3页 Journal of Medical Research
基金 黑龙江省自然科学基金资助项目(D2006-24) 黑龙江省卫生厅科研项目(2009-346) 佳木斯大学科技创新项目(CX2010-035和S2009-071)
关键词 生长素释放肽 慢性心力衰竭存活时间 心脏保护活性 GHRPs CHF Survival time Cardiaoprotective active
  • 相关文献

参考文献13

  • 1Bowers CY, Momany F, Reynolds GA, et al. Structure - activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology, 1980,106 ( 3 ) :663 - 667.
  • 2Bowers CY, Momany FA, Reynolds GA,et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 1984,114 (5) : 1537 - 1545.
  • 3陈晨.生长素释放肽的发现、发展及展望[J].基础医学与临床,2002,22(1):1-5. 被引量:5
  • 4Pang JJ, Xu RK, Xu XB, et al. Hexarelin protects rat cardiomyocytes from angiotensin II - induced apoptosis in vitro. Am J Physiol Heart Circ Physiol,2004,286 ( 3 ) : H1063 - H1069.
  • 5Cao JM, Ong H, Chen C. Effects of ghrelin and synthetic GH seeretagogues on the cardiovascular system. J Trends Endocrinol Metab, 2006,17(1) :13 - 18.
  • 6李梅秀,田国忠,欧叶涛,宋汉君,赵勇,王鹏.大鼠阿霉素慢性心衰模型的制备与心衰指标的判定[J].解剖学研究,2005,27(3):176-178. 被引量:43
  • 7曹济民.心力衰竭实验研究进展[J].基础医学与临床,2002,22(1):16-25. 被引量:35
  • 8Braunwald E,Bristow MR. Congestive heart failure: fifty years of progress. J Circulation ,2000,102 ( 20 Suppl 4 ) : IV14 - IV23.
  • 9Xu XB ,Pang JJ,Cao JM ,et al. GH - releasing peptides improve cardiac dysfunction and cachexia and suppress stress - related hormones and cardiomyoeyte apoptosis in rats with heart failure. Am J. Physiol Heart Circ Physiol,2005,289(4) :H1643 -H1651.
  • 10Marleau S, Mulumba M, Lamontagne D, et al. Cardiac and peripheral actions of growth hormone and its releasing peptides : relevance for the treatment of cardiomyopathies. Cardiovasc Res,2006,69 ( 1 ) :26 - 35.

二级参考文献127

  • 1王华军,陈金水,陈小明,吴天敏,许昌声,谢良地.阿霉素致大鼠心衰心肌肌球蛋白重链变化[J].中国实验动物学杂志,2001,11(4):202-202. 被引量:2
  • 2BOWERS CY, MOMANY F, REYNOLDS GA, et al. Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro [J]. Endocrinology, 1980, 106:663-667.
  • 3GUILLEMIN R, BRAZEAU P, BOHLEN P, et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly [J]. Science, 1982, 218:585-587.
  • 4HOWARD AD, FEIGHNER SD, CULLY DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release [J]. Science, 1996, 273:974-977.
  • 5DAVENPORT AP, BONNER TI, FOORD SM, et al. International Union of Pharmacology. LVI. Ghrelin receptor nomenclature, distribution, and function [J]. Pharmacol Rev, 2005, 57:541-546.
  • 6KOJIMA M, HOSODA H, DATE Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach [J]. Nature, 1999, 402:656-660.
  • 7LEITE-MOREIRA AF, SOARES JB. Physiological, pathological and potential therapeutic roles of ghrelin [J]. Drug Discov Today, 2007, 12:276-288.
  • 8MALAGON MM, LUQUE RM, RUIZ-GUERRERO E, et al. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes [J]. Endocrinology, 2003, 144:5372-5380.
  • 9HOSODA H, KOJIMA M, KANGAWA K. Biological, physiological, and pharmacological aspects of ghrelin [J]. J Pharmacol Sci, 2006, 100:398-410.
  • 10CAO JM, ONG H, CHEN C. Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system [J]. Trends Endocrinol Metab, 2006, 17:13-18.

共引文献84

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部